Additionally, they found that patients with concomitant NAFLD were less sensitive to insulin (estimated glucose distribution rate (eGDR)) and had a higher visceral adiposity index (VAI). This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.